Disc Medicine Inc. DEF 14A Filing on Executive Compensation
Ticker: IRON · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Disc Medicine DEF 14A out: exec comp & equity awards details for 2025. Formerly Gemini Therapeutics.
AI Summary
Disc Medicine, Inc. filed a DEF 14A on April 24, 2025, for the fiscal year ending December 31, 2025. The filing details executive compensation and equity awards granted in prior years that vested during the covered year, including changes in fair value for both "PeoMember" and "NonPeoNeoMember" categories. The company was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
Why It Matters
This filing provides transparency into how Disc Medicine Inc. compensates its top executives and the value of equity awards they received, which can impact investor perception and company performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not present new financial risks.
Key Numbers
- 20250424 — Filing Date (Date the DEF 14A was filed.)
- 20250611 — Period of Report (The period this filing pertains to.)
- 1231 — Fiscal Year End (The end date of the company's fiscal year.)
Key Players & Entities
- Disc Medicine, Inc. (company) — Filer
- Gemini Therapeutics, Inc. (company) — Former Company Name
- FS Development Corp. (company) — Former Company Name
- 0000950170-25-058142 (dollar_amount) — Accession Number
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a proxy statement filed by a company to solicit shareholder votes for annual meetings, typically including information on executive compensation, director nominations, and other corporate governance matters.
When was Disc Medicine, Inc. formerly known as Gemini Therapeutics, Inc.?
Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. as of February 9, 2021.
What is the business address of Disc Medicine, Inc.?
The business address of Disc Medicine, Inc. is 321 Arsenal Street, Suite 101, Watertown, MA 02472.
What is the SEC file number for Disc Medicine, Inc.?
The SEC file number for Disc Medicine, Inc. is 001-39438.
What does the 'PeoMember' and 'NonPeoNeoMember' designation likely refer to in the context of equity awards?
These designations likely refer to different categories of executive or employee members within the company, possibly distinguishing between principal executive officers ('PeoMember') and other non-principal executive officers or new employees ('NonPeoNeoMember'), for the purpose of reporting equity awards and their valuation.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding Disc Medicine, Inc. (IRON).